New Page 1
 

COPD-X Menu
COPD-X Menu COPD-X Home Page COPD-X Guidelines Management Tools Case Statements News & Resources COPD Institute Contact Us
COPD-X Menu

 

Refs 151-200

References 151 - 200

Refs 1 - 50 Refs 51 - 100 Refs 101 - 150 Refs 151 - 200 Refs 201 - 250 Refs 251 - 286
Note: [return to text] - goes to the last page in viewed in COPD-X regardless of reference number.
 
151 Gunes A, Aboyoun CL, Morton JM, Plit M, Malouf MA, Glanville AR. Lung transplantation for chronic obstructive pulmonary disease at St Vincent's Hospital. Intern Med J. 2006 Jan;36(1):5-11.
152   Jennings AL, Davies AN, Higgins JP, Gibbs JS, Broadley KE. A systematic review of the use of opioids in the management of dyspnoea. Thorax. 2002 Nov;57(11):939-44.
153  Tonnesen P, Carrozzi L, Fagerstrom KO, Gratziou C, Jimenez-Ruiz C, Nardini S, et al. Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy. Eur Respir J. 2007 Feb;29(2):390-417.
154  World Health Organization. Tobacco Free Initiative: Policies for Public Health. Geneva: World Health Organization; 1999.
155  A clinical practice guideline for treating tobacco use and dependence: A US Public Health Service report. The Tobacco Use and Dependence Clinical Practice Guideline Panel, Staff, and Consortium Representatives. Jama. 2000 Jun 28;283(24):3244-54.
156   Peters MJ, Morgan LC. The pharmacotherapy of smoking cessation. Med J Aust. 2002 May 20;176(10):486-90.
157  Wilson DH, Wakefield MA, Steven ID, Rohrsheim RA, Esterman AJ, Graham NM. "Sick of Smoking": evaluation of a targeted minimal smoking cessation intervention in general practice. Med J Aust. 1990 May 21;152(10):518-21.
158   Britton J, Knox A. Helping people to stop smoking: the new smoking cessation guidelines. Thorax. 1999 Jan;54(1):1-2.
159  Kottke TE, Battista RN, DeFriese GH, Brekke ML. Attributes of successful smoking cessation interventions in medical practice. A meta-analysis of 39 controlled trials. Jama. 1988 May 20;259(19):2883-9.
160   Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2004(3):CD000146.
161  Fiore MC, Smith SS, Jorenby DE, Baker TB. The effectiveness of the nicotine patch for smoking cessation. A meta-analysis. Jama. 1994 Jun 22-29;271(24):1940-7.
162   Fiore MC, Bailey WC, Cohen SJ. Smoking cessation: information for specialists. Rockville, MD: US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research and Centers for Disease Control and Prevention (AHCPR Publication No.96-0694); 1996.
163  Lancaster T, Stead L, Silagy C, Sowden A. Effectiveness of interventions to help people stop smoking: findings from the Cochrane Library. Bmj. 2000 Aug 5;321(7257):355-8.
164   Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, Hughes AR, et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med. 1999 Mar 4;340(9):685-91.
165  Schwartz JL. Review and Evaluation of Smoking Cessation Methods: The United States and Canada, 1978-1985 (NIH Publication No.87-2940). Bethesda, MD.: National Cancer Institute, National Institutes of Health; 1987.
166   Baillie AJ, Mattick RP, Hall W, Webster P. Meta-analytic review of the efficacy of smoking cessation interventions. Drug Alcohol Rev. 1994;13(2):157-70.
167  van der Meer RM, Wagena EJ, Ostelo RW, Jacobs JE, van Schayck CP. Smoking cessation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2003(2):CD002999.
168   Nichol KL, Margolis KL, Wuorenma J, Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med. 1994 Sep 22;331(12):778-84.
169  Poole PJ, Chacko E, Wood-Baker RW, Cates CJ. Influenza vaccine for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2006(1):CD002733.
170   Simberkoff MS, Cross AP, Al-Ibrahim M, Baltch AL, Geiseler PJ, Nadler J, et al. Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study. N Engl J Med. 1986 Nov 20;315(21):1318-27.
171  Granger R, Walters J, Poole PJ, Lasserson TJ, Mangtani P, Cates CJ, et al. Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2006(4):CD001390.
172   Williams JH, Jr., Moser KM. Pneumococcal vaccine and patients with chronic lung disease. Ann Intern Med. 1986 Jan;104(1):106-9.
173  Davis AL, Aranda CP, Schiffman G, Christianson LC. Pneumococcal infection and immunologic response to pneumococcal vaccine in chronic obstructive pulmonary disease. A pilot study. Chest. 1987 Aug;92(2):204-12.
174   Foxwell AR, Cripps AW, Dear KB. Haemophilus influenzae oral whole cell vaccination for preventing acute exacerbations of chronic bronchitis. Cochrane Database Syst Rev. 2003(3):CD001958.
175  Sprenkle MD, Niewoehner DE, MacDonald R, Rutks I, Wilt TJ. Clinical Efficacy of OM-85 BV in COPD and Chronic Bronchitis: A Systematic Review. COPD: Journal of Chronic Obstructive Pulmonary Disease. 2004;2(1):167 - 75.
176   Isada CM, Stoller JK. Chronic bronchitis: the role of antibiotics. In: Niederman MS, Sarosi GA, Glassroth J, eds. Respiratory Infections: a Scientific Basis for Management. London: WB Saunders 1994:621-33.
177  Siafakas NM, Bouros D. Management of acute exacerbation of chronic obstructive pulmonary disease. In: Postma D, Siafakas NM, eds. Management of Chronic Obstructive Pulmonary Disease. Sheffield: ERS Monograph 1998:264-77.
178   Black P, Staykova T, Chacko E, Ram FS, Poole P. Prophylactic antibiotic therapy for chronic bronchitis. Cochrane Database Syst Rev. 2003(1):CD004105.
179  Salpeter SR, Buckley NS, Salpeter EE. Meta-analysis: anticholinergics, but not beta-agonists, reduce severe exacerbations and respiratory mortality in COPD. J Gen Intern Med. 2006 Oct;21(10):1011-9.
180   Soriano JB, Sin DD, Zhang X, Camp PG, Anderson JA, Anthonisen NR, et al. A pooled analysis of FEV1 decline in COPD patients randomized to inhaled corticosteroids or placebo. Chest. 2007 Mar;131(3):682-9.
181  Highland KB, Strange C, Heffner JE. Long-term effects of inhaled corticosteroids on FEV1 in patients with chronic obstructive pulmonary disease. A meta-analysis. Ann Intern Med. 2003 Jun 17;138(12):969-73.
182   Sutherland ER, Allmers H, Ayas NT, Venn AJ, Martin RJ. Inhaled corticosteroids reduce the progression of airflow limitation in chronic obstructive pulmonary disease: a meta-analysis. Thorax. 2003 Nov;58(11):937-41.
183  Burge PS, Calverley PM, Jones PW, Spencer S, Anderson JA, Maslen TK. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. Bmj. 2000 May 13;320(7245):1297-303.
184   Alsaeedi A, Sin DD, McAlister FA. The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials. Am J Med. 2002 Jul;113(1):59-65.
185   Suissa S. Statistical treatment of exacerbations in therapeutic trials of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006 Apr 15;173(8):842-6.
186   Sin DD, Wu L, Anderson JA, Anthonisen NR, Buist AS, Burge PS, et al. Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax. 2005 Dec;60(12):992-7.
187   Poole PJ, Black PN. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2006;3:CD001287.
188   Decramer M, Rutten-van Molken M, Dekhuijzen PN, Troosters T, van Herwaarden C, Pellegrino R, et al. Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial. Lancet. 2005 Apr 30-May 6;365(9470):1552-60.
189   Siafakas NM, Vermeire P, Pride NB, Paoletti P, Gibson J, Howard P, et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J. 1995 Aug;8(8):1398-420.
190   Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. Am J Respir Crit Care Med. 1995 Nov;152(5 Pt 2):S77-121.
191  Tarpy SP, Celli BR. Long-term oxygen therapy. N Engl J Med. 1995 Sep 14;333(11):710-4.
192   Ram FS, Wedzicha JA. Ambulatory oxygen for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2002(2):CD000238.
193  Bradley JM, O'Neill B. Short term ambulatory oxygen for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2005(2):CD004356.
194   Turner SE, Eastwood PR, Cecins NM, Hillman DR, Jenkins SC. Physiologic responses to incremental and self-paced exercise in COPD: a comparison of three tests. Chest. 2004 Sep;126(3):766-73.
195   Cockcroft A, Beaumont A, Adams L, Guz A. Arterial oxygen desaturation during treadmill and bicycle exercise in patients with chronic obstructive airways disease. Clin Sci (Lond). 1985 Mar;68(3):327-32.
196  Poulain M, Durand F, Palomba B, Ceugniet F, Desplan J, Varray A, et al. 6-minute walk testing is more sensitive than maximal incremental cycle testing for detecting oxygen desaturation in patients with COPD. Chest. 2003 May;123(5):1401-7.
197   Nonoyama ML, Brooks D, Lacasse Y, Guyatt GH, Goldstein RS. Oxygen therapy during exercise training in chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2007(2):CD005372.
198  Bradley JM, Lasserson T, Elborn S, Macmahon J, O'Neill B. A systematic review of randomized controlled trials examining the short-term benefit of ambulatory oxygen in COPD. Chest. 2007 Jan;131(1):278-85.
1199   O'Neill B, Mahon JM, Bradley J. Short-burst oxygen therapy in chronic obstructive pulmonary disease. Respir Med. 2006 Jul;100(7):1129-38.
200  Managing passengers with respiratory disease planning air travel. British Thoracic Society recommendations. Thorax. 2002;57:289-304.
   

Next Page Previous Page